SEC Form 4 · accession 0001093557-17-000185
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Quentin S. Blackford
Officer — EVP, CFO, PFO & PAO
Period of report
Sep 7, 2017
Accepted (ET)
Sep 8, 2017 · 7:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 7, 2017 | A | 62,358 | $0.001 | A | 63,756 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a grant of restricted stock units that shall vest in four equal annual installments on September 7, 2018, September 7, 2019, September 7, 2020 and September 7, 2021. Share units represent a contingent right to receive one share of DexCom, Inc. Common Stock.
- F2Included in this number are 62,358 unvested restricted stock units which were granted on September 7, 2017 and shall vest through September 7, 2021.